Thanks for posting. It’s a clear explanation of what neo-adjuvant therapy is (immunotherapy before surgery) compared to normal adjuvant approaches (surgery then immunotherapy to prevent recurrence), with summaries of clinical trial evidence too. Very helpful resource for Stage III patients interested in this approach (I think it makes sense).
Viewing 0 reply threads
You must be logged in to reply to this topic.
About the MRF Patient Forum
The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.
The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.
.
.
